(HR) Healthcare Realty Trust - Ratings and Ratios

Healthcare Realty Trust Incorporated (NYSE: HR) is a real estate investment trust (REIT) specializing in medical outpatient facilities, strategically located near leading hospital campuses. The company focuses on acquiring and developing properties in high-growth markets, leveraging its position as the first and largest REIT dedicated to this niche. With a portfolio exceeding 650 properties and 38 million square feet across 15 growth markets, Healthcare Realty maintains a concentrated approach to capitalize on the demand for outpatient care infrastructure. Its strategic focus on medical office buildings and outpatient facilities positions it to benefit from evolving healthcare delivery trends. Web URL: https://www.healthcarerealty.com

Based on the provided data, here is a 3-month forecast for Healthcare Realty Trust Incorporated (NYSE: HR):

- Price Trend: The stock is currently trading below its 20-day, 50-day, and 200-day moving averages (SMA 20: 15.92, SMA 50: 16.31, SMA 200: 16.78), indicating a potential downtrend. - Volatility: Average True Range (ATR) of 0.43 suggests moderate price fluctuations. - Volume: Average 20-day volume of 2,823,991 shares indicates consistent trading activity.

- Valuation: The forward P/E of 10.83 suggests expectations of future earnings growth, while the P/B ratio of 1.07 indicates the stock is trading near book value. - Profitability: The negative Return on Equity (RoE) of -12.53 raises concerns about profitability. - Market Cap: With a market capitalization of $5.67 billion, the company is considered a mid-sized REIT.

3-Month Forecast: - The stock is likely to remain under pressure in the near term due to its position below key moving averages and negative profitability metrics. - Support levels may form near $15.00, while resistance could emerge at $16.50. - The forward P/E of 10.83 and moderate volume suggest potential stabilization, but upside may be limited without improvements in profitability. - Investors should monitor the companys ability to address its negative RoE and navigate the evolving healthcare real estate landscape.